debabrata
●    

2005-10-19 06:58

Posting: # 42
Views: 17,328
 

 Investigational Products for BA/BE [Regulatives / Guidelines]

According to Canadian Regulatory requirement, what is the retention sample quantity that has to be kept in the CRO after completion of the study? Also what is the retention period?
Helmut
★★★
avatar
Homepage
Vienna, Austria,
2005-10-19 11:22

@ debabrata
Posting: # 43
Views: 16,876
 

 Investigational Products for BA/BE

Hi!

'Preparation of Comparative Bioavailability Information for Drug Submissions in the CTD Format' (Draft Guidance, 2004-05-12) states:

Retention of Samples
It is recommended that samples of the test and reference drug products used in the comparative bioavailability study(ies), and the biological samples collected, including QC samples, be retained until the submission is either cleared or withdrawn.

Cheers,
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. ☼
Science Quotes
debabrata
●    

2005-10-20 07:22

@ debabrata
Posting: # 44
Views: 13,405
 

 Investigational Products for BA/BE

» According to Canadian Regulatory requirement, what is the retention sample quantity that has to be kept in the CRO after completion of the study? Also what is the retention period?

Is there any specific retention quantity that has to be kept in the CRO like US FDA?
H_Rotter
★    

Germany,
2005-10-20 15:43

@ debabrata
Posting: # 45
Views: 13,218
 

 Investigational Products for BA/BE

I don't think so; have you considered asking HPFB?

Regards,
Hermann
Activity
 Thread view
Bioequivalence and Bioavailability Forum |  Admin contact
19,688 posts in 4,178 threads, 1,353 registered users;
online 11 (0 registered, 11 guests [including 6 identified bots]).
Forum time (Europe/Vienna): 10:10 CEST

Power. That which statisticians are always calculating
but never have.    Stephen Senn

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
HTML5